Pan cancer patterns of allelic imbalance from chromosomal alterations in 33 tumor types.
allelic imbalance
cancer aneuploidy
copy number alterations
genomic instability
Journal
Genetics
ISSN: 1943-2631
Titre abrégé: Genetics
Pays: United States
ID NLM: 0374636
Informations de publication
Date de publication:
03 03 2021
03 03 2021
Historique:
received:
21
10
2020
revised:
22
11
2020
entrez:
8
3
2021
pubmed:
9
3
2021
medline:
13
8
2021
Statut:
ppublish
Résumé
Somatic copy number alterations (SCNAs) serve as hallmarks of tumorigenesis and often result in deviations from one-to-one allelic ratios at heterozygous loci, leading to allelic imbalance (AI). The Cancer Genome Atlas (TCGA) reports SCNAs identified using a circular binary segmentation algorithm, providing segment mean copy number estimates from single-nucleotide polymorphism DNA microarray total intensities (log R ratio), but not allele-specific intensities ("B allele" frequencies) that inform of AI. Our approach provides more sensitive identification of SCNAs by modeling the "B allele" frequencies jointly, thereby bolstering the catalog of chromosomal alterations in this widely utilized resource. Here we present AI summaries for all 33 tumor sites in TCGA, including those induced by SCNAs and copy-neutral loss-of-heterozygosity (cnLOH). We identified AI in 94% of the tumors, higher than in previous reports. Recurrent events included deletions of 17p, 9q, 3p, amplifications of 8q, 1q, 7p, as well as mixed event types on 8p and 13q. We also observed both site-specific and pan-cancer (spanning 17p) cnLOH, patterns which have not been comprehensively characterized. The identification of such cnLOH events elucidates tumor suppressors and multi-hit pathways to carcinogenesis. We also contrast the landscapes inferred from AI- and total intensity-derived SCNAs and propose an automated procedure to improve and adjust SCNAs in TCGA for cases where high levels of aneuploidy obscured baseline intensity identification. Our findings support the exploration of additional methods for robust automated inference procedures and to aid empirical discoveries across TCGA.
Identifiants
pubmed: 33683368
pii: 6078585
doi: 10.1093/genetics/iyaa021
pmc: PMC8045738
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-12Subventions
Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA181244
Pays : United States
Organisme : NHGRI NIH HHS
ID : R01 HG005855
Pays : United States
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of Genetics Society of America. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Références
Nat Commun. 2020 May 20;11(1):2517
pubmed: 32433464
Cell. 2014 Aug 14;158(4):929-944
pubmed: 25109877
Nature. 2015 Jan 29;517(7536):576-82
pubmed: 25631445
Nat Commun. 2020 Jan 23;11(1):449
pubmed: 31974379
N Engl J Med. 2016 Jan 14;374(2):135-45
pubmed: 26536169
Nat Rev Mol Cell Biol. 2010 Mar;11(3):220-8
pubmed: 20177397
Blood. 2010 Apr 8;115(14):2731-9
pubmed: 20107230
Science. 2017 Jan 20;355(6322):
pubmed: 28104840
Genet Epidemiol. 2010 Dec;34(8):816-34
pubmed: 21058334
PLoS One. 2012;7(10):e45950
pubmed: 23071531
Nat Rev Clin Oncol. 2017 Feb 20;14(3):140
pubmed: 28218256
Nat Genet. 2011 May;43(5):491-8
pubmed: 21478889
Mol Ther Oncolytics. 2020 May 26;17:562-570
pubmed: 32637574
Carcinogenesis. 2011 Apr;32(4):636-42
pubmed: 21297112
Nature. 2016 Mar 24;531(7595):471-475
pubmed: 26982726
Bioinformatics. 2016 Oct 1;32(19):3015-7
pubmed: 27288500
Nat Genet. 2008 Oct;40(10):1253-60
pubmed: 18776909
Blood Cancer J. 2014 May 02;4:e208
pubmed: 24786392
Cancer Cell. 2017 Mar 13;31(3):411-423
pubmed: 28292439
Cancer Cell. 2018 Apr 9;33(4):676-689.e3
pubmed: 29622463
Mol Cancer. 2014 Nov 06;13:246
pubmed: 25373456
Cell Rep. 2018 Apr 03;23(1):239-254.e6
pubmed: 29617664
Genome Res. 2013 Jan;23(1):152-8
pubmed: 23028187
Nat Genet. 2013 Oct;45(10):1134-40
pubmed: 24071852
Nat Genet. 2015 May;47(5):458-68
pubmed: 25848751
Cell. 2018 Apr 5;173(2):291-304.e6
pubmed: 29625048
Clin Cancer Res. 2000 Mar;6(3):1079-85
pubmed: 10741737
Biochim Biophys Acta. 2012 Jul;1819(7):784-93
pubmed: 22426433
J Natl Cancer Inst. 2018 Jul 1;110(7):704-713
pubmed: 29788099
Trends Cancer. 2016 Oct;2(10):561-571
pubmed: 28741487
Oncologist. 2016 Sep;21(9):1131-5
pubmed: 27401888